TWD 26.9
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 18.01 Million TWD | 34.74% |
2022 | 13.37 Million TWD | -7.82% |
2021 | 14.5 Million TWD | -9.16% |
2020 | 15.97 Million TWD | 52.33% |
2019 | 10.48 Million TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 4.51 Million TWD | 40.55% |
2024 Q2 | 12 Million TWD | 166.1% |
2023 FY | 18.01 Million TWD | 34.74% |
2023 Q4 | 3.21 Million TWD | -22.12% |
2023 Q3 | 4.12 Million TWD | -56.13% |
2023 Q2 | 9.39 Million TWD | 630.23% |
2023 Q1 | 1.28 Million TWD | 679.73% |
2022 Q4 | -221.99 Thousand TWD | 0.0% |
2022 FY | 13.37 Million TWD | -7.82% |
2021 FY | 14.5 Million TWD | -9.16% |
2020 FY | 15.97 Million TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -589.063% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | 81.38% |
Visgeneer Inc. | 67.48 Million TWD | 73.298% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 84.973% |
Advagene Biopharma Co., Ltd. | -12 Million TWD | 250.133% |
Sagittarius Life Science Corp | 71.47 Million TWD | 74.79% |
Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | 76.402% |
NaviFUS Corp. | 11.82 Million TWD | -52.355% |
BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | 79.894% |
Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | -170.271% |
TaiRx, Inc. | 2.43 Million TWD | -638.786% |
Sinew Pharma Inc. | -28.98 Million TWD | 162.167% |
Lin BioScience, Inc. | -17.92 Million TWD | 200.513% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 20.768% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 56.561% |
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -5376.9% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 82.732% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 95.524% |
Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 98.717% |
RBC Bioscience Corporation | 72.89 Million TWD | 75.281% |
3D Global Biotech Inc. | 5.27 Million TWD | -241.657% |
Level Biotechnology Inc. | 219.54 Million TWD | 91.793% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 94.271% |
TaiMed Biologics Inc. | 225.23 Million TWD | 92.0% |
Mycenax Biotech Inc. | -375.19 Million TWD | 104.803% |
SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | -3358.541% |
Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 547.233% |
Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | 90.92% |
Feng Chi Biotech Corp. | 80.72 Million TWD | 77.677% |
NeoCore Technology Co., Ltd. | -9.08 Million TWD | 298.338% |
Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | -5656.869% |
TWi Biotechnology, Inc. | -9.73 Million TWD | 285.019% |
Sunny Pharmtech Inc. | 285.52 Million TWD | 93.689% |
VBI | 16.42 Million TWD | -9.718% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -1563.804% |
BiOptic Inc. | 152.74 Million TWD | 88.203% |
Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 96.283% |
GeneReach Biotechnology Corp. | 27.58 Million TWD | 34.676% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 97.202% |
G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | 87.538% |
CHO Pharma, Inc. | -28.27 Million TWD | 163.719% |
AP Biosciences Inc | 32.25 Million TWD | 44.132% |
Senhwa Biosciences, Inc. | -10.17 Million TWD | 277.126% |
EirGenix Inc. | 236.74 Million TWD | 92.389% |
Enimmune corporation | -23.37 Million TWD | 177.093% |
Lukas Biomedical Inc. | 133.89 Million TWD | 86.542% |
GlycoNex Incorporation | 995 Thousand TWD | -1710.955% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -19921.111% |
Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 95.409% |
TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | 83.866% |
Medigen Biotechnology Corp. | 617.32 Million TWD | 97.081% |
Intech Biopharm Corporation | -163.99 Million TWD | 110.988% |
Oneness Biotech Co., Ltd. | 32.56 Million TWD | 44.662% |
TCI GENE Inc. | 174.61 Million TWD | 89.681% |
MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 208.542% |
NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | 76.587% |
PharmaEngine, Inc. | 718.97 Million TWD | 97.494% |
Savior Lifetec Corporation | 220.94 Million TWD | 91.845% |
OBI Pharma, Inc. | -73.49 Million TWD | 124.517% |
Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 92.173% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 87.025% |
Acepodia, Inc. | 16.59 Million TWD | -8.594% |
Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | 34.402% |